Inflarx Gmbh
Clinical trials sponsored by Inflarx Gmbh, explained in plain language.
-
Drug trial aims to heal painful, Hard-to-Treat skin wounds
Disease control TerminatedThis study tested whether the drug vilobelimab could help heal painful, open skin ulcers caused by a rare condition called pyoderma gangrenosum. About 54 adults with at least one qualifying ulcer received either the drug or a placebo. The main goal was to see if the drug could le…
Phase: PHASE3 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill tested for Tough-to-Treat skin conditions
Disease control TerminatedThis study tested a new oral pill called INF904 in adults with moderate to severe chronic spontaneous urticaria (hives) or hidradenitis suppurativa (a painful skin condition). The main goal was to check the drug's safety and how it moves through the body over a 28-day treatment p…
Phase: PHASE2 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC